Interestingly, nitro-fatty acids inhibited release of type I IFN in cells from patients with STING-associated vasculopathy with onset in infancy (SAVI)—a genetic disorder caused by gain-of-function mutations in STING (51, 52). This evidence concerns the gene STING1 and STING-associated vasculopathy with onset in infancy.